EUVIMEDEUVIMED entdecken
Crossref

Multidrug transporters P-GP, MRP1, and ABCG2 in chemoresistant breast and colorectal cancer cells—who takes the lead?

Sudipta Nath, Md. Akash, Md Tanim, Sharif Akhteruzzaman, Mohammad Mostafa, Abu Sajib

Journal of Advanced Biotechnology and Experimental Therapeutics · 2026 · 9 (1) · 1

DOI: 10.5455/jabet.2026.01 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Biotechnology and Experimental Therapeutics, 2026. Verfasst von Sudipta Nath und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite significant advances in the discovery and efficacy of anticancer drugs, chemoresistance remains a major issue in cancer treatment and management. Hyperactivity of efflux pumps is one of the key mechanisms through which cancer cells acquire chemoresistance. This study investigates the expression patterns of P-GP, MRP1, and ABCG2 in 49 paired chemoresistant breast and colorectal cancer tissues using immunofluorescence imaging and statistical applications. Among breast cancer patients, 92.86% were diagnosed with infiltrating ductal carcinoma, whereas in the case of colorectal cancer, 100% had adenocarcinoma. Our immunofluorescence data show concurrent expression of ABCG2, MRP1, and P-GP across all chemoresistant breast and colorectal cases, suggesting a synergistic action of these transporters in developing chemoresistance, although the expression level varied for the transporters. Expression of ABCG2 exceeded P-GP and MRP1 expression in most cases. We suggest that a combinative and targeted therapeutic approach may be beneficial to improve the prognosis of cases with chemoresistance.

Zitieren

APA

Nath, S., Akash, M., Tanim, M., Akhteruzzaman, S., Mostafa, M., & Sajib, A. (2026). Multidrug transporters P-GP, MRP1, and ABCG2 in chemoresistant breast and colorectal cancer cells—who takes the lead?. Journal of Advanced Biotechnology and Experimental Therapeutics, 9(1), 1. https://doi.org/10.5455/jabet.2026.01

Vancouver

Nath S, Akash M, Tanim M, Akhteruzzaman S, Mostafa M, Sajib A. Multidrug transporters P-GP, MRP1, and ABCG2 in chemoresistant breast and colorectal cancer cells—who takes the lead?. Journal of Advanced Biotechnology and Experimental Therapeutics. 2026;9(1):1. doi:10.5455/jabet.2026.01

BibTeX
@article{Nath2026,
  author = {Nath, Sudipta and Akash, Md. and Tanim, Md and Akhteruzzaman, Sharif and Mostafa, Mohammad and Sajib, Abu},
  title = {Multidrug transporters P-GP, MRP1, and ABCG2 in chemoresistant breast and colorectal cancer cells—who takes the lead?},
  journal = {Journal of Advanced Biotechnology and Experimental Therapeutics},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {1},
  doi = {10.5455/jabet.2026.01}
}
Kostenlos starten →